Inhibition of salivary secretion by tolterodine transdermal patch.

about

Inhibition of salivary secretion by tolterodine transdermal patch.

Item

http://www.wikidata.org/entity/Q48266047

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Inhibition of salivary secretion by tolterodine transdermal patch.

@en

Inhibition of salivary secretion by tolterodine transdermal patch.

@nl

type

Item

label

Inhibition of salivary secretion by tolterodine transdermal patch.

@en

Inhibition of salivary secretion by tolterodine transdermal patch.

@nl

prefLabel

Inhibition of salivary secretion by tolterodine transdermal patch.

@en

Inhibition of salivary secretion by tolterodine transdermal patch.

@nl

P1476

Inhibition of salivary secretion by tolterodine transdermal patch.

@en

P2093

Chang-Ik Choi

http://www.w3.org/2001/XMLSchema#string

Choon-Gon Jang

http://www.w3.org/2001/XMLSchema#string

Choong-Min Lee

http://www.w3.org/2001/XMLSchema#string

Ji-Yeong Byeon

http://www.w3.org/2001/XMLSchema#string

Jung-Woo Bae

http://www.w3.org/2001/XMLSchema#string

Se-Hyung Kim

http://www.w3.org/2001/XMLSchema#string

Seok-Yong Lee

http://www.w3.org/2001/XMLSchema#string

Young-Hoon Kim

http://www.w3.org/2001/XMLSchema#string

P2860

An update on the use of transdermal oxybutynin in the management of overactive bladder disorder

Effect of OROS controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride

Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence.

Using anticholinergics to treat overactive bladder: the issue of treatment tolerability.

Muscarinic receptor antagonists for overactive bladder.

Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review.

Muscarinic receptor subtypes and management of the overactive bladder.

Antimuscarinics and the overactive detrusor--which is the main mechanism of action?

Management of overactive bladder.

Management of overactive bladder and urge urinary incontinence in the elderly patient.

P2888

s12272-017-0988-9

P304

1455-1463

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12272-017-0988-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yun Jeong Lee

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29159581

http://www.w3.org/2001/XMLSchema#string